Crisaborole cream vs. placebo for mild to moderate eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests if a cream called crisaborole works better than a placebo cream for treating mild to moderate eczema. You'll apply the cream at home twice a day for four weeks, and researchers will see if it helps your skin heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 50 years old.
- You have mild to moderate eczema (not severe).
- You can apply the study cream at home twice a day for 4 weeks.
- You haven't used strong oral eczema medicines, immunosuppressants, or antibiotics in the last 2 weeks.
- You are not pregnant or nursing.
- You don't have other serious skin conditions like psoriasis or scabies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether crisaborole ointment works as well as tacrolimus ointment for children ages 2 to 18 with mild to moderate atopic dermatitis (eczema). If your child has eczema covering less than 30% of their body and hasn't used certain creams or medications recently, this study may be an option.
This trial tests an experimental cream or pill called ENV-294 in adults whose eczema is moderate to severe and hasn't gotten better with standard creams. It aims to see if ENV-294 can help control symptoms like itching and skin redness.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial compares two prescription creams, Crisaborole and Tacrolimus, to see which works better for treating atopic dermatitis (eczema) in people aged 5 to 25 with mild to moderate symptoms.
This study compares two prescription creams (tacrolimus and crisaborole) to see which works better and is safer for treating mild to moderate eczema in children and young adults aged 2–20. Both are non-steroid options that may help reduce itching and skin inflammation.
This trial tests if crisaborole ointment works better and is safer than tacrolimus ointment for mild to moderate atopic dermatitis (eczema). It may help you find a new treatment option.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.